Duncan McHale
Chief Tech/Sci/R&D Officer presso EVELO BIOSCIENCES, INC.
Patrimonio netto: 764 $ in data 31/03/2024
Profilo
Duncan McHale is the founder of Weatherden Ltd.
(founded in 2017) and holds the title of Director.
He is currently a Director at Excite Ventures Ltd.
and Chief Medical Officer at Evelo Biosciences, Inc. (since 2018).
Previously, he held the position of Head-Global Exploratory Development at UCB SA (2011-2017), ED & Head-Translational Molecular Medicine at Pfizer Ltd.
(1999-2008), and Vice President & Head-Translational Sciences at AstraZeneca Pharmaceuticals LP (1999-2011).
Dr. McHale obtained a doctorate degree from the University of Leeds in 1999 and an undergraduate degree from The University of Newcastle in 1991.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EVELO BIOSCIENCES, INC.
0.09% | 08/11/2023 | 16 984 ( 0.09% ) | 764 $ | 31/03/2024 |
Posizioni attive di Duncan McHale
| Società | Posizione | Inizio |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/02/2018 |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Founder | 01/04/2017 |
| Excite Ventures Ltd. | Director/Board Member | - |
Precedenti posizioni note di Duncan McHale
| Società | Posizione | Fine |
|---|---|---|
| UCB | Corporate Officer/Principal | 01/05/2017 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 01/08/2011 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Director/Board Member | 01/01/2008 |
Formazione di Duncan McHale
| University of Leeds | Doctorate Degree |
| The University of Newcastle | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UCB | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Weatherden Ltd.
Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Health Technology |
| Excite Ventures Ltd. |
- Borsa valori
- Insiders
- Duncan McHale
